Evidence map›Paper›PMID 33345924›Full record

SynthesisAmerican journal of obstetrics & gynecology MFM2020

Antenatal corticosteroids in preterm small-for-gestational age infants: a systematic review and meta-analysis.

Stephanie A Blankenship, Kristine E Brown, Laura E Simon, Molly J Stout, Methodius G Tuuli

Open access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in American journal of obstetrics & gynecology MFM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Stephanie A BlankenshipDepartment of Obstetrics and Gynecology, Washington University School of Medicine in St. Louis, St. Louis, MO. Electronic address: 7sblank@gmail.com.
Kristine E BrownDepartment of Obstetrics and Gynecology, Washington University School of Medicine in St. Louis, St. Louis, MO.
Laura E SimonBernard Becker Medical Library, Washington University School of Medicine in St. Louis, St. Louis, MO.
Molly J StoutDepartment of Obstetrics and Gynecology, Washington University School of Medicine in St. Louis, St. Louis, MO.
Methodius G TuuliDepartment of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN.
Washington University in St. Louis · USIndiana University School of Medicine

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Optimizing Management of the Second Stage of Labor: Multicenter Randomized TrialU01HD077384 · NICHD · WASHINGTON UNIVERSITY · PI CAHILL, ALISON G, TUULI, METHODIUS GAMUO · 2014 to 2019
$7.8M
THE VAGINAL MICROBIOME, MATERNAL RESPONSE, AND PRETERM BIRTHR01HD095986 · NICHD · WASHINGTON UNIVERSITY · PI STOUT, MOLLY, WYLIE, KRISTINE M. · 2018 to 2022
$3.2M
Prophylactic Negative Pressure Wound Therapy in Obese Women at Cesarean: Multicenter Randomized TrialR01HD086007 · NICHD · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI HARPER, LORIE M, TUULI, METHODIUS GAMUO · 2016 to 2019
$2.6M
Women's Reproductive Health Research Career Development Program at W.U., St LouisK12HD063086 · NICHD · WASHINGTON UNIVERSITY · PI MACONES, GEORGE A · 2009 to 2013
$2.6M
Reproductive Epidemiology Training Program at Washington University in St. LouisT32HD055172 · NICHD · WASHINGTON UNIVERSITY · PI MADDEN, TESSA · 2009 to 2018
$2.5M
NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NICHD NIH HHS K12 HD063086NICHD NIH HHS R01 HD086007NICHD NIH HHS R01 HD095986NICHD NIH HHS T32 HD055172NICHD NIH HHS U01 HD077384
6 · The paper itself

Abstract

objectiveThis study aimed to estimate the effect of antenatal corticosteroid administration on neonatal mortality and morbidity in preterm small-for-gestational age infants through a systematic review and meta-analysis. DATA SOURCES: A predefined, systematic search was conducted through Ovid MEDLINE, Embase, Scopus, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, World Health Organization International Clinical Trial Registry Platform, and ClinicalTrials.gov yielding 5324 articles from 1970 to 2019. STUDY ELIGIBILITY CRITERIA: Eligible studies compared neonatal morbidity and mortality among small-for-gestational age infants delivered preterm who received antenatal corticosteroids with those who did not.

methodsThe primary outcome was neonatal mortality. Secondary outcomes were respiratory distress syndrome, necrotizing enterocolitis, intraventricular hemorrhage and periventricular leukomalacia, bronchopulmonary dysplasia or chronic lung disease of prematurity, or neonatal sepsis. We assessed heterogeneity by means of Higgins I

resultsA total of 16 observational cohort and case-control studies published from 1995 to 2018 met the selection criteria for the systematic review and included 8989 preterm small-for-gestational age infants. Antenatal corticosteroid administration was explicitly reported among 8376 small-for-gestational age infants; 4631 (55.3%) received antenatal corticosteroids and 3741 (44.7%) did not. Of note, 13 studies including 6387 preterm small-for-gestational age infants were then included in the meta-analysis. Neonatal mortality was significantly lower among infants who received antenatal corticosteroids than those who did not (12 studies: 12.8% vs 15.1%; pooled odds ratio, 0.63; 95% confidence interval, 0.46-0.86), with significant heterogeneity between studies (I

conclusionThese data indicate that antenatal corticosteroid administration reduces neonatal mortality in small-for-gestational age infants delivered preterm, with no apparent effect on neonatal morbidity. This supports the use of antenatal corticosteroids to reduce neonatal mortality in pregnancies with small-for-gestational age infants at risk of preterm birth.

Indexed as

Bronchopulmonary DysplasiaPremature BirthRespiratory Distress Syndrome, NewbornAdrenal Cortex HormonesFemaleGestational AgeHumansInfantInfant, NewbornPregnancyAdrenal Cortex Hormonesantenatal corticosteroidsfetal growth restrictionneonatal morbidityneonatal mortalitysmall-for-gestational age

Identifiers

PMID33345924
PMCPMC8237697
OpenAlexW3067431854

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.